Patented Supplement Ingredients Decoded: KSM-66, BioPerine, Creapure, and What Actually Justifies the Premium (2026)

"Patented ingredient" is a marketing phrase, not a quality grade. A patent protects a novel extraction, a novel form, or a novel composition — it says nothing about whether the resulting material is more effective than the generic equivalent. Some branded ingredients (KSM-66, Creapure, Suntheanine, Theracurmin) have substantial human clinical trial data on the specific branded form, and the premium is defensible. Others are patents on extraction methods with little or no comparative human data against generic material, and the premium is largely a marketing asset. This guide separates the two, using published clinical trials, PubMed searches, and industry supplier documentation.

What a supplement-ingredient patent actually protects

A US or EU patent on a dietary ingredient typically covers one or more of:

• A specific extraction solvent or process
• A specific standardization ratio (for example, a fixed percentage of a marker compound)
• A novel physical form (nanoparticle, phytosome, liposomal, micellar)
• A novel composition (combining two compounds in a fixed ratio)

None of those by itself means clinical superiority. Clinical superiority requires head-to-head trials in humans showing the branded form outperforms the generic. That evidence exists for a minority of branded ingredients.

Branded ingredients with substantial clinical evidence on the specific form

KSM-66 ashwagandha (Ixoreal)

KSM-66 is a root-only, milk-extracted, ~5% withanolide-standardized ashwagandha extract. Published human RCTs on KSM-66 specifically exceed 30 and cover stress, sleep, strength, and testosterone endpoints (Chandrasekhar 2012 Indian J Psychol Med; Salve 2019 Cureus; Wankhede 2015 J Int Soc Sports Nutr). The branded premium is defensible when the clinical claim matches the trial endpoints.

Sensoril ashwagandha (Natreon)

Sensoril is a different ashwagandha extract, root-and-leaf, standardized to ≥10% withanolides. Has its own clinical trials (Auddy 2008 JANA; Raut 2012 J Ayurveda Integr Med), typically at lower doses (125-250 mg) than KSM-66 (300-600 mg). Evidence exists; it is a different ingredient with different standardization, not the same thing.

Theracurmin (Theravalues)

A submicron-particle colloidal curcumin. Pharmacokinetic studies show markedly higher bioavailability versus standard curcumin (Sasaki 2011 Biol Pharm Bull; Kanai 2013 Cancer Chemother Pharmacol). Clinical trials on cognitive, cardiovascular, and musculoskeletal endpoints exist on Theracurmin specifically.

Meriva / Curcumin Phytosome (Indena)

Curcumin complexed with phosphatidylcholine. Comparative pharmacokinetic studies show higher absorption (Cuomo 2011 J Nat Prod). Trials in osteoarthritis, diabetes, and other indications are published on the Meriva form.

Longvida (Verdure Sciences)

A solid-lipid curcumin particle with published pharmacokinetics (Gota 2010 J Agric Food Chem) and clinical trials including cognitive and cardiovascular endpoints (DiSilvestro 2012 Nutr J).

Creapure (AlzChem / Universal Nutrition distribution)

Creatine monohydrate produced by the AlzChem plant in Germany. The branded premium is primarily a purity and heavy-metal story — Creapure lots are tested to tight specifications and consistently show lower detectable contaminants than generic Chinese creatine in independent testing. Clinical evidence on creatine monohydrate as a molecule is overwhelming (hundreds of RCTs), so the brand premium is a manufacturing quality premium, which is a defensible reason.

Suntheanine (Taiyo)

A patented enzymatic process yields pure L-theanine (vs racemic D/L mixtures in some cheap supplies). Most major L-theanine clinical trials used Suntheanine (Nobre 2008 Asia Pac J Clin Nutr; Kimura 2007 Biol Psychol).

Setria glutathione (Kyowa Hakko)

A fermented L-glutathione with published clinical trials showing elevations in body glutathione stores (Richie 2015 Eur J Nutr). Note: oral glutathione bioavailability remains debated; Setria has the best direct evidence.

BioPerine (Sabinsa)

A 95% piperine extract standardized for use as an absorption enhancer. The landmark trial (Shoba 1998 Planta Med) showed ~2000% increased bioavailability of curcumin when co-administered with 20 mg piperine. BioPerine's trials are on piperine; many human studies have used the BioPerine brand. The evidence is for piperine-as-enhancer; other 95% piperine extracts would be expected to perform similarly.

Capros / amla extract, Crominex 3+, and others

Sabinsa and similar ingredient suppliers maintain dozens of branded extracts with varying evidence quality. Look at the trial count and sample size on the specific branded form.

Branded ingredients with thin or non-comparative evidence

Many "patented" ingredient names appear on labels primarily because the brand wants a trademark on the panel. Common patterns:

• Patents on extraction solvents with no published comparative human trials
• Patents on combination ratios where the individual ingredients have data but the combination does not
• "Clinically studied" claims that reference a single small open-label study
• Trademarks on what is essentially a generic ingredient

Flag these when: (a) PubMed returns fewer than three RCTs on the specific branded name, (b) no trial directly compares the branded form to a generic equivalent, and (c) marketing copy relies heavily on a single unpublished "proprietary study."

Evidence-ranked comparison

Branded ingredient	What is patented	Human RCTs on the specific branded form	Generic alternative viable?	Premium justified?
KSM-66 ashwagandha	Extract process, standardization	30+	Generic 5% withanolide extract at ~50% price	Often yes, when dose matches trials
Sensoril ashwagandha	Extract process, standardization	~10-15	Generic with similar withanolide %	Often yes
Theracurmin	Submicron particle form	20+	Standard curcumin at higher dose	Yes if bioavailability matters
Meriva (curcumin phytosome)	Phospholipid complex	20+	Standard curcumin	Yes if absorption matters
Longvida	Solid-lipid particle	10+	Standard curcumin	Yes for cognitive endpoints
Creapure creatine	Source facility	Hundreds on creatine; Creapure specifically for purity	Bulk creatine monohydrate	Manufacturing-quality yes
Suntheanine	Enzymatic synthesis process	10+	Generic L-theanine (variable purity)	Usually yes
Setria glutathione	Fermentation process	5+	Liposomal alternatives	Debatable; best direct evidence
BioPerine	Standardized 95% piperine	20+ as enhancer	Generic 95% piperine	Marginal; mechanism is class-level
TruCurcumin / various generic-style curcumins	Extraction, ratio	0-2 on the specific brand	Standard curcumin	Often no
Proprietary amino-acid blends	Ratio	0-1 on the blend	Individual amino acids	Usually no
Trademarked generic extracts	Trademark only	0-1	Generic	No

How to evaluate any branded ingredient on a label in 60 seconds

1. Search PubMed for the branded name in quotes. Count the RCTs in humans. Fewer than three should trigger skepticism.
2. Check if the trials used the dose listed on the product, not a higher dose.
3. Look for a head-to-head study versus the generic. If absent, ask whether the class-level mechanism (piperine as absorption enhancer, creatine as creatine) makes brand differentiation meaningful.
4. Confirm the brand's third-party testing — a patented ingredient is only as clean as the lot that made it into the bottle.

How Nutrola thinks about ingredient selection

Nutrola Daily Essentials uses ingredient forms chosen on published clinical evidence at the listed dose, not on trademark portfolio. The formulation posts per-ingredient doses (not proprietary blends), lab test results, and holds EU certification. Flat $49/month, no MLM pricing, no hidden-dose blends. Across app and supplement users, Nutrola holds 4.9 across 1,340,080 reviews. For daily nutrient tracking that respects this evidence hierarchy, the Nutrola app is €2.50/month with zero ads and 100+ nutrients tracked.

Frequently Asked Questions

Does a patent number on the label mean a product is better?

No. A patent means the supplier filed and received intellectual-property protection for a process, form, or composition. It does not attest to clinical superiority. The relevant question is whether human clinical trials on the specific branded form support the health claim at the listed dose.

Is KSM-66 always the right ashwagandha choice?

Often, for general stress and strength endpoints where 300-600 mg daily matches the trial dosing. Sensoril is a reasonable alternative at lower doses for different endpoints. Generic 5% withanolide extracts are a third option at lower cost, though they carry more lot variability.

Why is Creapure more expensive if creatine is creatine?

The molecule is the same. The premium reflects manufacturing quality — lower detectable heavy metals and creatinine, consistent particle size, third-party purity testing. For athletes subject to testing, Creapure lots are generally Informed-Sport-compatible.

Does BioPerine actually improve absorption for every ingredient?

No. Piperine as a class enhances absorption of some compounds (curcumin, selenium, CoQ10) meaningfully and others marginally. Adding BioPerine to ingredients with already-high absorption is cosmetic. The mechanism is class-level, so other 95% piperine extracts should work similarly.

Is it worth paying for patented forms at all?

Sometimes. For curcumin, the bioavailability gap between standard curcumin and enhanced forms (Theracurmin, Meriva, Longvida) is real and clinically meaningful. For ashwagandha, the branded extracts have the bulk of the trial evidence. For creatine, the gap is about purity, not molecule. Ask what problem the premium solves — and whether that problem is your problem.

---

References: Chandrasekhar K et al. 2012 Indian J Psychol Med; Salve J et al. 2019 Cureus; Wankhede S et al. 2015 J Int Soc Sports Nutr; Auddy B et al. 2008 JANA; Sasaki H et al. 2011 Biol Pharm Bull; Kanai M et al. 2013 Cancer Chemother Pharmacol; Cuomo J et al. 2011 J Nat Prod; Gota VS et al. 2010 J Agric Food Chem; DiSilvestro RA et al. 2012 Nutr J; Nobre AC et al. 2008 Asia Pac J Clin Nutr; Kimura K et al. 2007 Biol Psychol; Richie JP et al. 2015 Eur J Nutr; Shoba G et al. 1998 Planta Med.